That's the only news out there on AZN.
"AstraZeneca (AZN.L)slipped 2.7% to the bottom of the blue-chip index after HSBC analysts cut the target price on the drugmaker's stock to 13,720p from 14,070p." |
Any idea why this is 3% Down or more overhang from China? |
AstraZeneca today announced the appointment of Iskra Reic as Executive Vice President (EVP), International with responsibility for overall strategy and driving sustainable growth across this broad region.
This encompasses China, Asian and Eurasian markets, Middle East & Africa, Latin America, Australia & New Zealand.
Iskra succeeds Leon Wang who is on extended leave from the Company while under investigation in China. |
benralizumab first new treatment for Asthma and COPD for 50 years and injection every 4 to 8 weeks looks like a game changer to me .
AZN share price is sure to fall today
Edit
. benralizumab/Fasenra looks to have been in phase 3 trials since 2013 why would it take so long ,or has there been some improvements made in benralizumab /Fasenra .
cost seems a little high $5197 per ml
It was approved by US and EU regulators in 2017 but just 7 years later they find that its by injection that it can stop severe asthma and COPD attacks 4 times better than the standard steroid treatment.Better late than never I would say. |
Price (GBX)
10,474.00 -% (-)
Open / Last close
10,484.00 / 10,474.00
High / Low
10,546.00 / 10,404.00
Bid / Offer
10,474.00 / 10,476.00
Special Condition: -
Trading Status: Normal - Closed
FTSE 100
As at 25.11.24 20:36:09 GMT
LSE |
ASTRAZENECA : Goldman Sachs reaffirms its Buy rating
November 25, 2024 at 12:33 pm
Rajan Sharma from Goldman Sachs retains his positive opinion on the stock with a Buy rating. The target price is unchanged and still at GBX 15955. |
The UK stock market never fails to amaze me down 4p on this news,Hope top management actually start to think about this nonsense and move the listing to the US it must be blatantly obvious to them that the UK is not the place for AZN .
If this was a US listed company do you think that the share price would react in this manner.
Prostate cancer is the second most prevalent cancer in men and the fifth leading cause of male cancer death globally.1 |
The UK stock market never fails to amaze me down 4p on this news,Hope top management actually start to think about this nonsense and move the listing to the US it must be blatantly obvious to them that the UK is not the place for AZN .
If this was a US listed company do you think that the share price would react in this manner.
Prostate cancer is the second most prevalent cancer in men and the fifth leading cause of male cancer death globally.1 |
JP Morgan Cazenove out with strong buy this morning with £140 share price forecast. |
Slowly creeping up.Mkt obvs forgotton abt China |
Non Exec director purchase stateside
3,000 @ USD 63.398167 = $190,000 |
UBS raises AstraZeneca to 'neutral' (sell) - price target 11,300 pence
Berenberg cuts AstraZeneca price target to 14,000 (15,000) pence - 'buy' |
I don't take much notice of a target price. They always seem about the same percentage away from where the price actually stands depending on where their analysis is going. I just look for the buy, sell, hold as a gauge. Berenberg actually quoted 14000 from 15000, whilst maintaining a buy rating.Other than that, I apologise as I don't understand your comment. |
Not sure if you have realised but the current share price is slighty higher than the 140p analyst rating. |
Still a 'buy' rating. |
* AstraZeneca AZN.L: Berenberg cuts target price to 140p from 150pBerenberg seem incredibpy bearish ? |
Yes a bit of fun is good for the morale ! |
s,
No, No. WTFRU?
Come on be BOULD! |
Bit of fun in-between.Who are you ? |
WTF has happened to this BB.
Come back Buywell. All is forgiven. |
Breaking RNS soon as Demand and Revenue increases with Mega Deals in the pipeline.
Get on the Train to Success and Beyond.
Happy Days Ahead... |
That's hard call |
With Government helped finance, AstraZeneca should buy out Pfizer, then, as we would have the rights to Viagra, the economy may stay up longer. |
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hot Features
Premium
